ASX - By Stock
|
SMN |
Re:
Ann: Voluntary Suspension
|
|
Braddozack
|
19 |
7.7K |
1 |
08/11/17 |
08/11/17 |
ASX - By Stock
|
19
|
7.7K
|
1
|
|
ASX - By Stock
|
SMN |
Re:
Has the worm turned?
|
|
Braddozack
|
79 |
32K |
2 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
79
|
32K
|
2
|
|
ASX - By Stock
|
SMN |
Re:
Has the worm turned?
|
|
Braddozack
|
79 |
32K |
1 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
79
|
32K
|
1
|
|
ASX - By Stock
|
SMN |
Re:
Has the worm turned?
|
|
Braddozack
|
79 |
32K |
2 |
19/10/17 |
19/10/17 |
ASX - By Stock
|
79
|
32K
|
2
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust secures core Europe patent
|
|
Braddozack
|
12 |
5.9K |
2 |
21/09/17 |
21/09/17 |
ASX - By Stock
|
12
|
5.9K
|
2
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust secures core Europe patent
|
|
Braddozack
|
12 |
5.9K |
3 |
21/09/17 |
21/09/17 |
ASX - By Stock
|
12
|
5.9K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
Double bottom
|
|
Braddozack
|
54 |
21K |
4 |
04/09/17 |
04/09/17 |
ASX - By Stock
|
54
|
21K
|
4
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Investor Presentation
|
|
Braddozack
|
3 |
1.5K |
7 |
30/08/17 |
30/08/17 |
ASX - By Stock
|
3
|
1.5K
|
7
|
|
ASX - By Stock
|
SMN |
Re:
Broker Data
|
|
Braddozack
|
48 |
16K |
4 |
29/08/17 |
29/08/17 |
ASX - By Stock
|
48
|
16K
|
4
|
|
ASX - By Stock
|
SMN |
Re:
Broker Data
|
|
Braddozack
|
48 |
16K |
3 |
29/08/17 |
29/08/17 |
ASX - By Stock
|
48
|
16K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
Broker Data
|
|
Braddozack
|
48 |
16K |
1 |
29/08/17 |
29/08/17 |
ASX - By Stock
|
48
|
16K
|
1
|
|
ASX - By Stock
|
SMN |
Re:
Change in wave count
|
|
Braddozack
|
44 |
14K |
7 |
29/08/17 |
29/08/17 |
ASX - By Stock
|
44
|
14K
|
7
|
|
ASX - By Stock
|
SMN |
Re:
Change in wave count
|
|
Braddozack
|
44 |
14K |
0 |
25/08/17 |
25/08/17 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
SMN |
Re:
Webinar
|
|
Braddozack
|
158 |
54K |
9 |
25/08/17 |
25/08/17 |
ASX - By Stock
|
158
|
54K
|
9
|
|
ASX - By Stock
|
SMN |
Re:
Webinar
|
|
Braddozack
|
158 |
54K |
3 |
25/08/17 |
25/08/17 |
ASX - By Stock
|
158
|
54K
|
3
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Shareholders Update
|
|
Braddozack
|
13 |
6.4K |
3 |
25/08/17 |
25/08/17 |
ASX - By Stock
|
13
|
6.4K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
Webinar
|
|
Braddozack
|
158 |
54K |
0 |
23/08/17 |
23/08/17 |
ASX - By Stock
|
158
|
54K
|
0
|
|
ASX - By Stock
|
SMN |
Re:
Webinar
|
|
Braddozack
|
158 |
54K |
4 |
23/08/17 |
23/08/17 |
ASX - By Stock
|
158
|
54K
|
4
|
|
ASX - By Stock
|
SMN |
Re:
Webinar
|
|
Braddozack
|
158 |
54K |
4 |
23/08/17 |
23/08/17 |
ASX - By Stock
|
158
|
54K
|
4
|
|
ASX - By Stock
|
SMN |
Re:
Webinar
|
|
Braddozack
|
158 |
54K |
2 |
23/08/17 |
23/08/17 |
ASX - By Stock
|
158
|
54K
|
2
|
|
ASX - By Stock
|
SMN |
Re:
Ann: SMS executes world first agreement with Delta Airlines
|
|
Braddozack
|
146 |
67K |
0 |
22/08/17 |
22/08/17 |
ASX - By Stock
|
146
|
67K
|
0
|
|
ASX - By Stock
|
SMN |
Re:
Ann: SMS executes world first agreement with Delta Airlines
|
|
Braddozack
|
146 |
67K |
3 |
18/08/17 |
18/08/17 |
ASX - By Stock
|
146
|
67K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
Ann: SMS executes world first agreement with Delta Airlines
|
|
Braddozack
|
146 |
67K |
3 |
18/08/17 |
18/08/17 |
ASX - By Stock
|
146
|
67K
|
3
|
|
ASX - By Stock
|
NUZ |
Re:
Biotech growth story....hideously oversold
|
|
Braddozack
|
21 |
8.8K |
1 |
17/08/17 |
17/08/17 |
ASX - By Stock
|
21
|
8.8K
|
1
|
|
ASX - By Stock
|
SMN |
Re:
Ann: Trading Halt
|
|
Braddozack
|
95 |
42K |
15 |
16/08/17 |
16/08/17 |
ASX - By Stock
|
95
|
42K
|
15
|
|
ASX - By Stock
|
NUZ |
Re:
Lymphoma update
|
|
Braddozack
|
9 |
3.6K |
7 |
13/08/17 |
13/08/17 |
ASX - By Stock
|
9
|
3.6K
|
7
|
|
ASX - By Stock
|
NUZ |
Re:
Biotech growth story....hideously oversold
|
|
Braddozack
|
21 |
8.8K |
3 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
21
|
8.8K
|
3
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C - Quarterly Report & Brief Company Update
|
|
Braddozack
|
28 |
10K |
2 |
01/08/17 |
01/08/17 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C - Quarterly Report & Brief Company Update
|
|
Braddozack
|
28 |
10K |
2 |
01/08/17 |
01/08/17 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C - Quarterly Report & Brief Company Update
|
|
Braddozack
|
28 |
10K |
1 |
01/08/17 |
01/08/17 |
ASX - By Stock
|
28
|
10K
|
1
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C - Quarterly Report & Brief Company Update
|
|
Braddozack
|
28 |
10K |
4 |
01/08/17 |
01/08/17 |
ASX - By Stock
|
28
|
10K
|
4
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C - Quarterly Report & Brief Company Update
|
|
Braddozack
|
28 |
10K |
12 |
01/08/17 |
01/08/17 |
ASX - By Stock
|
28
|
10K
|
12
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C - Quarterly Report & Brief Company Update
|
|
Braddozack
|
28 |
10K |
2 |
01/08/17 |
01/08/17 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
NUZ |
Re:
Possible breakout
|
|
Braddozack
|
129 |
44K |
6 |
31/07/17 |
31/07/17 |
ASX - By Stock
|
129
|
44K
|
6
|
|
ASX - By Stock
|
NUZ |
Re:
Possible breakout
|
|
Braddozack
|
129 |
44K |
4 |
31/07/17 |
31/07/17 |
ASX - By Stock
|
129
|
44K
|
4
|
|
ASX - By Stock
|
NUZ |
Re:
Possible breakout
|
|
Braddozack
|
129 |
44K |
3 |
26/07/17 |
26/07/17 |
ASX - By Stock
|
129
|
44K
|
3
|
|
ASX - By Stock
|
NUZ |
Re:
Possible breakout
|
|
Braddozack
|
129 |
44K |
8 |
26/07/17 |
26/07/17 |
ASX - By Stock
|
129
|
44K
|
8
|
|
ASX - By Stock
|
CF1 |
Re:
Ann: Initger - Sentry Group Pty Ltd Heads of Agreement Update
|
|
Braddozack
|
386 |
161K |
11 |
07/06/17 |
07/06/17 |
ASX - By Stock
|
386
|
161K
|
11
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Shareholders Update and Roadmap
|
|
Braddozack
|
22 |
9.7K |
1 |
02/06/17 |
02/06/17 |
ASX - By Stock
|
22
|
9.7K
|
1
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Shareholders Update and Roadmap
|
|
Braddozack
|
22 |
9.7K |
8 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
22
|
9.7K
|
8
|
|
ASX - By Stock
|
CF1 |
Re:
Moving on
|
|
Braddozack
|
307 |
125K |
0 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
307
|
125K
|
0
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Shareholders Update and Roadmap
|
|
Braddozack
|
22 |
9.7K |
2 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
22
|
9.7K
|
2
|
|
ASX - By Stock
|
CF1 |
Re:
Moving on
|
|
Braddozack
|
307 |
125K |
0 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
307
|
125K
|
0
|
|
ASX - By Stock
|
CF1 |
Re:
Moving on
|
|
Braddozack
|
307 |
125K |
0 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
307
|
125K
|
0
|
|
ASX - By Stock
|
CF1 |
Re:
Moving on
|
|
Braddozack
|
307 |
125K |
2 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
307
|
125K
|
2
|
|
ASX - By Stock
|
CF1 |
Re:
Moving on
|
|
Braddozack
|
307 |
125K |
0 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
307
|
125K
|
0
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Shareholders Update and Roadmap
|
|
Braddozack
|
22 |
9.7K |
2 |
30/05/17 |
30/05/17 |
ASX - By Stock
|
22
|
9.7K
|
2
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Shareholders Update and Roadmap
|
|
Braddozack
|
22 |
9.7K |
9 |
30/05/17 |
30/05/17 |
ASX - By Stock
|
22
|
9.7K
|
9
|
|
ASX - By Stock
|
NUZ |
Re:
Broker lunch in Sydney and upside
|
|
Braddozack
|
18 |
11K |
8 |
29/05/17 |
29/05/17 |
ASX - By Stock
|
18
|
11K
|
8
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Phase II trial prelim results demonstrate clinical benefit
|
|
Braddozack
|
32 |
13K |
19 |
19/05/17 |
19/05/17 |
ASX - By Stock
|
32
|
13K
|
19
|
|